Future research into methods to treat obesity in Asia will need to take into account the potential effectiveness of bariatric surgery and the recent development of new, hormone-modulating drugs being developed to counter leptin resistance and ghrelin imbalances [155]. This evidence concerns the gene GHRL and obesity due to melanocortin 4 receptor deficiency.